Screening breast MRIs should be considered for women with a personal history of breast cancer.
Women who have had breast cancer are at risk for subsequent breast cancers and should be screened by MRI, according to a study published in the American Journal of Roentgenology.
Researchers from the United States and Japan undertook a retrospective review of screening breast MRIs to assess the importance of a personal history of breast cancer as a risk factor for patients who were referred for screening breast MRI.
The study involved reviewing MR images of 702 patients that were performed from 2004 to 2012. A total of 465 patients underwent annual MRI and 237 had one every six months as part of a research protocol.
The researchers found that of the patients screened, 208 had a personal history of breast cancer and 345 had a family history of breast cancer as the sole risk factor. Ninety-seven patients had both risk factors. The absolute risk for detection of breast cancer at screening MRI was 2.8 percent among patients with a personal history of cancer, and 2.0 percent for patients with a strong family history of cancer.
“The relative risk for detection of breast cancer given a personal history was 1.42 compared with family history,” the authors wrote. “The relative risk when both risk factors were present compared with having only a family history was 3.04.”
The researchers concluded that a personal history of breast cancer was an important risk factor for the development of subsequent breast cancer and should be reason for patients in this group to undergo breast MRI screening.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.